Craig C. Hopkinson

CIK 1730048 · EVP R&D, Chief Medical Officer · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$3.83M

Companies

2

Total Filings

54

Lifetime Open-Market Net

-$23.42M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ALKS	EVP R&D, Chief Medical Officer	86,389	$44.28	$3.83M	-$23.42M	52	2026-06-01
ALBIREO PHARMA, INC. (ALBO) Delisted	Director	10,495	$44.15	$463.4K	$0	2	2023-03-02

Recent Filings · Page 5 of 6

54 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-04-16	ALKS	Sell (S)	−28,920	-$570.3K	EDGAR
2021-02-24	ALKS	Grant (A)	—	$0	EDGAR
2021-02-23	ALKS	Mixed	+11,884	-$99.6K	EDGAR
2021-02-18	ALKS	Mixed	+2,203	-$23.2K	EDGAR
2021-01-15	ALKS	Exer (M)	+6,875	$0	EDGAR
2020-06-08	ALKS	Mixed	+882	-$6.3K	EDGAR
2020-02-24	ALKS	Mixed	+4,871	-$40.6K	EDGAR
2020-02-18	ALKS	Mixed	+2,203	-$20.8K	EDGAR
2019-06-10	ALKS	Mixed	+882	-$8.4K	EDGAR
2019-02-25	ALKS	Grant (A)	—	$0	EDGAR

Showing 41–50 of 54

Prev Page 5 of 6 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.